US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Esophageal Cancer
Recent news which mentions Esophageal Cancer
Bristol Myers' Two Opdivo Based Regimes Under FDA Review For Esophageal Cancer
September 27, 2021
Tickers
BMY
Tags
FDA
BMY
News
From
Benzinga
Junshi Biosciences, Coherus Share Toripalimab Survival Data In Esophageal Cancer
September 17, 2021
Tickers
CHRS
Tags
News
Health Care
Esophageal Cancer
From
Benzinga
Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial
September 16, 2021
Tickers
BGNE
NVS
ZYME
Tags
ESMO21
Long Ideas
Briefs
From
Benzinga